L. Colloca and F. Benedetti, Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci, pp.545-52, 2005.

W. Häuser, E. Hansen, and P. Enck, Nocebo phenomena in medicine: their relevance in everyday clinical practice, Dtsch Ärztebl Int, vol.109, issue.26, p.459, 2012.

W. Kennedy, The nocebo reaction. Med World, pp.203-208, 1961.

R. Hahn, The nocebo phenomenon: Scope and foundations. The placebo effect: An interdisciplinary exploration, pp.56-76, 1997.

P. Enck, F. Benedetti, and M. Schedlowski, New Insights into the Placebo and Nocebo Responses, Neuron, vol.59, issue.2, pp.195-206, 2008.
DOI : 10.1016/j.neuron.2008.06.030

A. Barsky, R. Saintfort, M. Rogers, and J. Borus, Nonspecific Medication Side Effects and the Nocebo Phenomenon, JAMA, vol.287, issue.5, pp.622-629, 2002.
DOI : 10.1001/jama.287.5.622

S. Klosterhalfen, S. Kellermann, S. Braun, A. Kowalski, M. Schrauth et al., Gender and the nocebo response following conditioning and expectancy, Journal of Psychosomatic Research, vol.66, issue.4, pp.323-331, 2009.
DOI : 10.1016/j.jpsychores.2008.09.019

R. Casper, G. Tollefson, and M. Nilsson, No gender differences in placebo responses of patients with major depressive disorder, Biological Psychiatry, vol.49, issue.2, pp.158-60, 2001.
DOI : 10.1016/S0006-3223(00)00966-5

M. Drici, F. Raybaud, C. Lunardo, P. Iacono, and P. Gustovic, Influence of the behaviour pattern on the nocebo response of healthy volunteers., British Journal of Clinical Pharmacology, vol.16, issue.2, pp.204-210, 1995.
DOI : 10.1111/j.1365-2125.1995.tb04434.x

G. Liccardi, G. Senna, M. Russo, P. Bonadonna, M. Crivellaro et al., Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions, J Investig Allergol Clin Immunol, vol.14, issue.2, pp.104-111, 2004.

J. Data-franco and M. Berk, The nocebo effect: A clinicians guide, Australian & New Zealand Journal of Psychiatry, vol.64, issue.7, pp.617-640, 2013.
DOI : 10.1016/j.pain.2010.08.007

A. Geers, S. Helfer, K. Kosbab, P. Weiland, and S. Landry, Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response, Journal of Psychosomatic Research, vol.58, issue.2, pp.121-128, 2005.
DOI : 10.1016/j.jpsychores.2004.08.011

R. Hahn, The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health, Preventive Medicine, vol.26, issue.5, pp.607-618, 1997.
DOI : 10.1006/pmed.1996.0124

J. Williams, R. Sade, D. Amico, and T. , Framing for Success: Nocebo Effects in Thoracic Surgery, The Annals of Thoracic Surgery, vol.95, issue.1, pp.9-11, 2013.
DOI : 10.1016/j.athoracsur.2012.10.048

K. Faasse and K. Petrie, The nocebo effect: patient expectations and medication side effects, Postgraduate Medical Journal, vol.109, issue.Suppl 188, pp.540-546, 1055.
DOI : 10.1136/postgradmedj-2012-131730

F. Benedetti and M. Amanzio, The placebo response: how words and rituals change the patient's brain. Patient Educ Couns, pp.413-422, 2011.

A. Geers, S. Helfer, P. Weiland, and K. Kosbab, Expectations and Placebo Response: A Laboratory Investigation into the Role of Somatic Focus, Journal of Behavioral Medicine, vol.56, issue.2, 2006.
DOI : 10.1007/s10865-005-9040-5

F. Benedetti, Placebo-Induced Improvements: How Therapeutic Rituals Affect the Patient's Brain, Journal of Acupuncture and Meridian Studies, vol.5, issue.3, pp.97-103
DOI : 10.1016/j.jams.2012.03.001

L. Atlas and T. Wager, How expectations shape pain, Neuroscience Letters, vol.520, issue.2, p.2012
DOI : 10.1016/j.neulet.2012.03.039

R. Reeves, M. Ladner, R. Hart, and R. Burke, Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry, pp.275-282, 2007.

F. Benedetti, M. Amanzio, C. Casadio, A. Oliaro, and G. Maggi, Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide, Pain, vol.71, issue.2, pp.135-175, 1997.
DOI : 10.1016/S0304-3959(97)03346-0

T. Lovick, Pro-nociceptive action of cholecystokinin in the periaqueductal grey: A role in neuropathic and anxiety-induced hyperalgesic states, Neuroscience & Biobehavioral Reviews, vol.32, issue.4, 2008.
DOI : 10.1016/j.neubiorev.2008.01.003

F. Benedetti, M. Amanzio, S. Vighetti, and G. Asteggiano, The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect, Journal of Neuroscience, vol.26, issue.46, pp.12014-12036, 2006.
DOI : 10.1523/JNEUROSCI.2947-06.2006

D. Scott, C. Stohler, C. Egnatuk, H. Wang, R. Koeppe et al., Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses, Archives of General Psychiatry, vol.65, issue.2, p.220, 2008.
DOI : 10.1001/archgenpsychiatry.2007.34

F. Benedetti, M. Lanotte, L. Lopiano, and L. Colloca, When words are painful: Unraveling the mechanisms of the nocebo effect, Neuroscience, vol.147, issue.2, pp.260-71, 2007.
DOI : 10.1016/j.neuroscience.2007.02.020

L. Colloca and D. Finniss, Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes, JAMA, vol.307, issue.6, pp.567-575, 2012.
DOI : 10.1001/jama.2012.115

R. Wells and T. Kaptchuk, To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent, The American Journal of Bioethics, vol.130, issue.11, pp.22-31, 2012.
DOI : 10.1213/ANE.0b013e3181cc5727

L. Colloca and F. Miller, The Nocebo Effect and Its Relevance for Clinical Practice, Psychosomatic Medicine, vol.73, issue.7, pp.598-603, 2011.
DOI : 10.1097/PSY.0b013e3182294a50

C. Sanderson, J. Hardy, O. Spruyt, and D. Currow, Placebo and Nocebo Effects in Randomized Controlled Trials: The Implications for Research and Practice, Journal of Pain and Symptom Management, vol.46, issue.5, pp.722-752, 2013.
DOI : 10.1016/j.jpainsymman.2012.12.005

L. Colloca and F. Miller, Harnessing the placebo effect: the need for translational research, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.5, issue.12, 1572.
DOI : 10.1371/journal.pone.0015591

D. Mitsikostas, L. Mantonakis, and N. Chalarakis, Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches, Cephalalgia, vol.19, issue.5, pp.550-61, 2011.
DOI : 10.1016/j.ncl.2008.11.011

R. Bortner, A short rating scale as a potential measure of pattern a behavior, Journal of Chronic Diseases, vol.22, issue.2, pp.87-91, 1969.
DOI : 10.1016/0021-9681(69)90061-7

J. Stellman and C. Dufresne, Encyclopédie de sécurité et de santé au travail. International Labour Organization, 2000.

A. Zigmond and R. Snaith, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-70, 1983.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

D. Razavi, N. Delvaux, C. Farvacques, and E. Robaye, Validation de la version française du HADS dans une population de patients cancéreux hospitalisés, Rev Psychol Appliquée, vol.39, issue.4, pp.295-307, 1989.

A. Untas, M. Aguirrezabal, P. Chauveau, E. Leguen, C. Combe et al., Anxiété et dépression en hémodialyse : validation de l'Hospital Anxiety and Depression Scale (HADS) Néphrologie Thérapeutique, pp.193-200, 2009.

M. Hamilton, A RATING SCALE FOR DEPRESSION, Journal of Neurology, Neurosurgery & Psychiatry, vol.23, issue.1, pp.56-62, 1960.
DOI : 10.1136/jnnp.23.1.56

S. Montgomery and M. Asberg, A new depression scale designed to be sensitive to change, The British Journal of Psychiatry, vol.134, issue.4, pp.382-391, 1979.
DOI : 10.1192/bjp.134.4.382

A. Beck, C. Ward, M. Mendelson, J. Mock, and J. Erbaugh, An Inventory for Measuring Depression, Archives of General Psychiatry, vol.4, issue.6, pp.561-71, 1961.
DOI : 10.1001/archpsyc.1961.01710120031004

I. Bergeri, R. Michel, and J. Boutin, Pour tout savoir ou presque sur le coefficient kappa, Médecine Trop, vol.62, issue.6, pp.634-640, 2002.

T. Perneger and A. Perrier, Analyse d'un test diagnostique : courbe ROC, ou « receiver operating characteristic ». Rev Mal Respir, pp.398-401, 2004.

M. Law and B. Mintzes, The Sources and Popularity of Online Drug Information: An Analysis of Top Search Engine Results and Web Page Views, Annals of Pharmacotherapy, vol.26, issue.3, pp.350-356, 2011.
DOI : 10.1345/aph.1P572

S. Patris-vandesteene, A. Macrez, J. Quenon, F. Soury, P. Rufat et al., Information des patients : évaluation de leurs connaissances après prescription de médicaments dans un CHU parisien, J Pharm Clin, vol.21, issue.2, pp.115-136, 2002.

B. Allenet, A. Guignon, P. Maire, and J. Calop, Intégration des représentations de la personne âgée face à ses médicaments pour améliorer son observance, J Pharm Clin, vol.24, issue.3, pp.175-184, 2005.

M. Amanzio, L. Corazzini, L. Vase, and F. Benedetti, A systematic review of adverse events in placebo groups of anti-migraine clinical trials, Pain, vol.146, issue.3, pp.261-270, 2009.
DOI : 10.1016/j.pain.2009.07.010

W. Rief, J. Avorn, and A. Barsky, Medication-Attributed Adverse Effects in Placebo Groups, Archives of Internal Medicine, vol.166, issue.2, 2006.
DOI : 10.1001/archinte.166.2.155

W. Rief, Y. Nestoriuc, S. Weiss, E. Welzel, A. Barsky et al., Meta-analysis of the placebo response in antidepressant trials, Journal of Affective Disorders, vol.118, issue.1-3, pp.1-31, 2009.
DOI : 10.1016/j.jad.2009.01.029

D. Papadopoulos and D. Mitsikostas, A meta-analytic approach to estimating nocebo effects in neuropathic pain trials, Journal of Neurology, vol.67, issue.3, pp.436-483, 2012.
DOI : 10.1007/s00415-011-6197-4

M. Rogers, Headaches and the nocebo effect, Headache, vol.43, issue.10, pp.1113-1118, 2003.

L. Colloca and F. Benedetti, Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci, pp.545-52, 2005.

W. Häuser, E. Hansen, and P. Enck, Nocebo phenomena in medicine: their relevance in everyday clinical practice, Dtsch Ärztebl Int, vol.109, issue.26, pp.459-65, 2012.

L. Colloca and F. Miller, Harnessing the placebo effect: the need for translational research, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.5, issue.12, 1572.
DOI : 10.1371/journal.pone.0015591

P. Enck, F. Benedetti, and M. Schedlowski, New Insights into the Placebo and Nocebo Responses, Neuron, vol.59, issue.2, pp.195-206, 2008.
DOI : 10.1016/j.neuron.2008.06.030

F. Benedetti, M. Lanotte, L. Lopiano, and L. Colloca, When words are painful: Unraveling the mechanisms of the nocebo effect, Neuroscience, vol.147, issue.2, pp.260-71, 2007.
DOI : 10.1016/j.neuroscience.2007.02.020

A. Conti, Nocebos and nocebo effects still exist though Hippocrates had recommended that patients would not be harmed. Med Hypotheses, pp.207-215, 2010.

I. Edwards, J. Graedon, and T. Graedon, Placebo Harm, Drug Safety, vol.68, issue.11, p.439, 2010.
DOI : 10.2165/11532400-000000000-00000

W. Kennedy, The nocebo reaction. Med World, pp.203-208, 1961.

R. Wells and T. Kaptchuk, To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent, The American Journal of Bioethics, vol.130, issue.11, pp.22-31, 2012.
DOI : 10.1213/ANE.0b013e3181cc5727

F. Benedetti and M. Amanzio, The placebo response: how words and rituals change the patient's brain. Patient Educ Couns, pp.413-422, 2011.

R. Hahn, The nocebo phenomenon: Scope and foundations. The placebo effect: An interdisciplinary exploration, pp.56-76, 1997.

M. Teixeira, C. Guedes, P. Barreto, and M. Martins, The placebo effect and homeopathy, Homeopathy, vol.99, issue.2, pp.119-148, 2010.
DOI : 10.1016/j.homp.2010.02.001

D. Mitsikostas, L. Mantonakis, and N. Chalarakis, Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches, Cephalalgia, vol.19, issue.5, pp.550-61, 2011.
DOI : 10.1016/j.ncl.2008.11.011

D. Papadopoulos and D. Mitsikostas, A meta-analytic approach to estimating nocebo effects in neuropathic pain trials, Journal of Neurology, vol.67, issue.3, pp.436-483, 2012.
DOI : 10.1007/s00415-011-6197-4

M. Cepeda, V. Lobanov, and J. Berlin, Use of ClinicalTrials.gov to estimate conditionspecific nocebo effects and other factors affecting outcomes of analgesic trials, J Pain. 2013, vol.14, issue.4, pp.405-416

W. Häuser, P. Sarzi-puttini, T. Tölle, and F. Wolfe, Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis, Clin Exp Rheumatol, vol.30, issue.6, pp.78-87, 2012.

D. Varelmann, C. Pancaro, E. Cappiello, and W. Camann, Nocebo-Induced Hyperalgesia During Local Anesthetic Injection, Anesthesia & Analgesia, vol.110, issue.3, pp.868-70, 2010.
DOI : 10.1213/ANE.0b013e3181cc5727

S. Elsenbruch, J. Schmid, M. Bäsler, E. Cesko, M. Schedlowski et al., How positive and negative expectations shape the experience of visceral pain: an experimental pilot study in healthy women, Neurogastroenterology & Motility, vol.3, issue.Suppl. 1, pp.914-460, 2012.
DOI : 10.1111/j.1365-2982.2012.01950.x

C. Okaïs, C. Gay, F. Seon, L. Buchaille, E. Chary et al., Disease-specific adverse events following nonlive vaccines: A paradoxical placebo effect or a nocebo phenomenon?, Vaccine, vol.29, issue.37, pp.6321-6327, 2011.
DOI : 10.1016/j.vaccine.2011.05.045

G. Liccardi, G. Senna, M. Russo, P. Bonadonna, M. Crivellaro et al., Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions, J Investig Allergol Clin Immunol, vol.14, issue.2, pp.104-111, 2004.

J. Weissenfeld, S. Stock, M. Lungen, and A. Gerber, The nocebo effect: a reason for patients non-adherence to generic substitution? Pharm, Int J Pharm Sci, vol.65, issue.7, pp.451-457, 2010.

K. Faasse and K. Petrie, The nocebo effect: patient expectations and medication side effects, Postgraduate Medical Journal, vol.109, issue.Suppl 188, pp.540-546, 1055.
DOI : 10.1136/postgradmedj-2012-131730

N. Mondaini, P. Gontero, G. Giubilei, G. Lombardi, T. Cai et al., T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?, Sexologies, vol.17, issue.6, pp.1708-1720, 2007.
DOI : 10.1016/S1158-1360(08)72795-6

P. Vernia, D. Camillo, M. Foglietta, T. Avallone, V. et al., Diagnosis of lactose intolerance and the « nocebo » effect: The role of negative expectations. Dig Liver Dis, pp.616-625, 2010.

T. Kaptchuk, Sham device v inert pill: randomised controlled trial of two placebo treatments, BMJ, vol.332, issue.7538, pp.391-398, 2006.
DOI : 10.1136/bmj.38726.603310.55

R. Voelker, Nocebos contribute to host of ills, JAMA. Feb, vol.7275, issue.5, pp.345-352, 1996.

R. Bootzin and E. Bailey, Understanding placebo, nocebo, and iatrogenic treatment effects, Journal of Clinical Psychology, vol.51, issue.7, pp.871-80, 2005.
DOI : 10.1002/jclp.20131

S. Haga, L. Warner, O. Daniel, and J. , The Potential of a Placebo/Nocebo Effect in Pharmacogenetics, Public Health Genomics, vol.12, issue.3, pp.158-62, 2009.
DOI : 10.1159/000189628

A. Pollo, E. Torre, L. Lopiano, M. Rizzone, M. Lanotte et al., Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients, Neuroreport, vol.13, issue.11, pp.1383-1389, 2002.
DOI : 10.1097/00001756-200208070-00006

S. Chapman, S. George, and A. , How the factoid of wind turbines causing ???vibroacoustic disease??? came to be ???irrefutably demonstrated???, Australian and New Zealand Journal of Public Health, vol.9, issue.8, 2013.
DOI : 10.1111/1753-6405.12066

R. Szemerszky, F. Köteles, R. Lihi, and G. Bárdos, Polluted places or polluted minds? An experimental sham-exposure study on background psychological factors of symptom formation in ???Idiophatic Environmental Intolerance attributed to electromagnetic fields???, International Journal of Hygiene and Environmental Health, vol.213, issue.5
DOI : 10.1016/j.ijheh.2010.05.001

M. Röösli, Radiofrequency electromagnetic field exposure and non-specific symptoms of ill health: A systematic review, Environmental Research, vol.107, issue.2, pp.277-87, 2008.
DOI : 10.1016/j.envres.2008.02.003

G. Rubin, R. Nieto-hernandez, and S. Wessely, Idiopathic environmental intolerance attributed to electromagnetic fields (formerly ???electromagnetic hypersensitivity???): An updated systematic review of provocation studies, Bioelectromagnetics, vol.27, issue.Suppl 4, 2010.
DOI : 10.1002/bem.20536

C. Daughton, Ground Water Recharge and Chemical Contaminants: Challenges in Communicating the Connections and Collisions of Two Disparate Worlds, Ground Water Monitoring & Remediation, vol.86, issue.1, pp.127-165, 2004.
DOI : 10.1111/j.1745-6592.2004.tb00721.x

U. Bingel, V. Wanigasekera, K. Wiech, R. Mhuircheartaigh, M. Lee et al., The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil, Science Translational Medicine, vol.3, issue.70, pp.70-84, 2011.
DOI : 10.1126/scitranslmed.3001244

G. Meynen and D. Swaab, Why medication in involuntary treatment may be less effective: The placebo/nocebo effect, Medical Hypotheses, vol.77, issue.6, pp.993-998, 2011.
DOI : 10.1016/j.mehy.2011.08.029

L. Colloca and F. Miller, The Nocebo Effect and Its Relevance for Clinical Practice, Psychosomatic Medicine, vol.73, issue.7, pp.598-603, 2011.
DOI : 10.1097/PSY.0b013e3182294a50

S. Klosterhalfen, S. Kellermann, S. Braun, A. Kowalski, M. Schrauth et al., Gender and the nocebo response following conditioning and expectancy, Journal of Psychosomatic Research, vol.66, issue.4, pp.323-331, 2009.
DOI : 10.1016/j.jpsychores.2008.09.019

R. Casper, G. Tollefson, and M. Nilsson, No gender differences in placebo responses of patients with major depressive disorder, Biological Psychiatry, vol.49, issue.2, pp.158-60, 2001.
DOI : 10.1016/S0006-3223(00)00966-5

A. Barsky, R. Saintfort, M. Rogers, and J. Borus, Nonspecific Medication Side Effects and the Nocebo Phenomenon, JAMA, vol.287, issue.5, pp.622-629, 2002.
DOI : 10.1001/jama.287.5.622

A. Terracciano, A. Scuteri, J. Strait, A. Sutin, O. Meirelles et al., Are personality traits associated with white-coat and masked hypertension?, Journal of Hypertension, vol.32, issue.10, 2014.
DOI : 10.1097/HJH.0000000000000289

M. Drici, F. Raybaud, C. Lunardo, P. Iacono, and P. Gustovic, Influence of the behaviour pattern on the nocebo response of healthy volunteers., British Journal of Clinical Pharmacology, vol.16, issue.2, pp.204-210, 1995.
DOI : 10.1111/j.1365-2125.1995.tb04434.x

J. Data-franco and M. Berk, The nocebo effect: A clinicians guide, Australian & New Zealand Journal of Psychiatry, vol.64, issue.7, pp.617-640
DOI : 10.1016/j.pain.2010.08.007

A. Geers, S. Helfer, K. Kosbab, P. Weiland, and S. Landry, Reconsidering the role of personality in placebo effects: Dispositional optimism, situational expectations, and the placebo response, Journal of Psychosomatic Research, vol.58, issue.2, pp.121-128, 2005.
DOI : 10.1016/j.jpsychores.2004.08.011

R. Hahn, The Nocebo Phenomenon: Concept, Evidence, and Implications for Public Health, Preventive Medicine, vol.26, issue.5, pp.607-618, 1997.
DOI : 10.1006/pmed.1996.0124

M. Rogers, Headaches and the nocebo effect, Headache, vol.43, issue.10, pp.1113-1118, 2003.

R. Reeves, M. Ladner, R. Hart, and R. Burke, Nocebo effects with antidepressant clinical drug trial placebos. Gen Hosp Psychiatry, pp.275-282, 2007.

J. Williams, R. Sade, D. Amico, and T. , Framing for Success: Nocebo Effects in Thoracic Surgery, The Annals of Thoracic Surgery, vol.95, issue.1, pp.9-11, 2013.
DOI : 10.1016/j.athoracsur.2012.10.048

A. De-craen, P. Roos, L. De-vries, A. Kleijnen, and J. , Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness, BMJ, vol.313, issue.7072, pp.1624-1630, 1996.
DOI : 10.1136/bmj.313.7072.1624

F. Benedetti, Placebo-Induced Improvements: How Therapeutic Rituals Affect the Patient's Brain, Journal of Acupuncture and Meridian Studies, vol.5, issue.3, pp.97-103
DOI : 10.1016/j.jams.2012.03.001

A. Geers, S. Helfer, P. Weiland, and K. Kosbab, Expectations and Placebo Response: A Laboratory Investigation into the Role of Somatic Focus, Journal of Behavioral Medicine, vol.56, issue.2, 2006.
DOI : 10.1007/s10865-005-9040-5

C. Clark, I. Horvath, R. Taylor, and J. Campbell, Doctors record higher blood pressures than nurses: systematic review and meta-analysis, British Journal of General Practice, vol.64, issue.621, pp.223-255
DOI : 10.3399/bjgp14X677851

L. Colloca, P. Petrovic, T. Wager, M. Ingvar, and F. Benedetti, How the number of learning trials affects placebo and nocebo responses, Pain, vol.151, issue.2, pp.430-439, 2010.
DOI : 10.1016/j.pain.2010.08.007

A. Barsky and J. Borus, Functional Somatic Syndromes, Annals of Internal Medicine, vol.130, issue.11, pp.910-931, 1999.
DOI : 10.7326/0003-4819-130-11-199906010-00016

A. Geers, J. Wellman, S. Fowler, S. Helfer, and C. France, Dispositional Optimism Predicts Placebo Analgesia, The Journal of Pain, vol.11, issue.11, pp.1165-71, 2010.
DOI : 10.1016/j.jpain.2010.02.014

J. Pennebaker and J. Skelton, Selective monitoring of physical sensations., Journal of Personality and Social Psychology, vol.41, issue.2, pp.213-236, 1981.
DOI : 10.1037/0022-3514.41.2.213

L. Nes and S. Segerstrom, Dispositional Optimism and Coping: A Meta-Analytic Review, Personality and Social Psychology Review, vol.60, issue.3, pp.235-51, 2006.
DOI : 10.1207/s15327957pspr1003_3

E. Vögtle, A. Barke, and B. Kröner-herwig, Nocebo hyperalgesia induced by social observational learning, Pain, vol.154, issue.8, pp.1427-1460, 2013.
DOI : 10.1016/j.pain.2013.04.041

M. Colligan and L. Murphy, Mass psychogenic illness in organizations: An overview, Journal of Occupational Psychology, vol.52, issue.2, pp.77-90, 1979.
DOI : 10.1111/j.2044-8325.1979.tb00444.x

L. Atlas and T. Wager, How expectations shape pain, Neuroscience Letters, vol.520, issue.2, p.2012
DOI : 10.1016/j.neulet.2012.03.039

M. Flaten, P. Aslaksen, P. Lyby, and E. Bjorkedal, The relation of emotions to placebo responses, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.106, issue.6, pp.1818-1845, 1572.
DOI : 10.1097/01.anes.0000265418.68005.8a

L. Colloca, L. Lopiano, M. Lanotte, and F. Benedetti, Overt versus covert treatment for pain, anxiety, and Parkinson's disease, The Lancet Neurology, vol.3, issue.11, pp.679-84, 2004.
DOI : 10.1016/S1474-4422(04)00908-1

C. Sanderson, J. Hardy, O. Spruyt, and D. Currow, Placebo and Nocebo Effects in Randomized Controlled Trials: The Implications for Research and Practice, Journal of Pain and Symptom Management, vol.46, issue.5, pp.722-752, 2013.
DOI : 10.1016/j.jpainsymman.2012.12.005

T. Lovick, Pro-nociceptive action of cholecystokinin in the periaqueductal grey: A role in neuropathic and anxiety-induced hyperalgesic states, Neuroscience & Biobehavioral Reviews, vol.32, issue.4, 2008.
DOI : 10.1016/j.neubiorev.2008.01.003

F. Benedetti, M. Amanzio, C. Casadio, A. Oliaro, and G. Maggi, Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide, Pain, vol.71, issue.2, pp.135-175, 1997.
DOI : 10.1016/S0304-3959(97)03346-0

F. Benedetti, M. Amanzio, S. Vighetti, and G. Asteggiano, The Biochemical and Neuroendocrine Bases of the Hyperalgesic Nocebo Effect, Journal of Neuroscience, vol.26, issue.46, pp.12014-12036, 2006.
DOI : 10.1523/JNEUROSCI.2947-06.2006

J. Levine, N. Gordon, and H. Fields, The mechanism of placebo analgesia, Lancet, vol.2, issue.8091, pp.654-661, 1978.

D. Scott, C. Stohler, C. Egnatuk, H. Wang, R. Koeppe et al., Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses, Archives of General Psychiatry, vol.65, issue.2, p.220, 2008.
DOI : 10.1001/archgenpsychiatry.2007.34

J. Kong, R. Gollub, G. Polich, I. Kirsch, P. Laviolette et al., A Functional Magnetic Resonance Imaging Study on the Neural Mechanisms of Hyperalgesic Nocebo Effect, Journal of Neuroscience, vol.28, issue.49, pp.13354-62, 2008.
DOI : 10.1523/JNEUROSCI.2944-08.2008

R. Moss-morris, J. Weinman, K. Petrie, R. Horne, L. Cameron et al., The Revised Illness Perception Questionnaire (IPQ-R), Psychology & Health, vol.26, issue.1, pp.1-16, 2002.
DOI : 10.1348/135910700168900

R. Horne, J. Weinman, and M. Hankins, The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication, Psychology & Health, vol.39, issue.1, pp.1-24, 1999.
DOI : 10.1159/000288663

R. Horne, K. Faasse, V. Cooper, M. Diefenbach, H. Leventhal et al., The perceived sensitivity to medicines (PSM) scale: An evaluation of validity and reliability, British Journal of Health Psychology, vol.67, issue.6, pp.18-30, 2013.
DOI : 10.1111/j.2044-8287.2012.02071.x

L. Colloca and D. Finniss, Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes, JAMA, vol.307, issue.6, pp.567-575
DOI : 10.1001/jama.2012.115

O. Connor, A. Pennie, R. Dales, and R. , Framing effects on expectations, decisions, and side effects experienced: The case of influenza immunization, Journal of Clinical Epidemiology, vol.49, issue.11, pp.1271-1277, 1996.
DOI : 10.1016/S0895-4356(96)00177-1

F. Miller and L. Colloca, The placebo phenomenon and medical ethics: Rethinking the relationship between informed consent and risk???benefit assessment, Theoretical Medicine and Bioethics, vol.124, issue.7651, pp.229-272, 2011.
DOI : 10.1007/s11017-011-9179-8

J. Berthelot, The placebo effect in rheumatology: New data, Joint Bone Spine, vol.78, issue.2, pp.161-166, 2011.
DOI : 10.1016/j.jbspin.2010.08.006

J. Berthelot, Y. Maugars, M. Abgrall, and A. Prost, Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses, Joint Bone Spine, vol.68, issue.1, pp.65-70, 2001.
DOI : 10.1016/S1297-319X(00)00225-6

S. Davies, P. Jackson, L. Ramsay, and P. Ghahramani, Drug Intolerance Due to Nonspecific Adverse Effects Related to Psychiatric Morbidity in Hypertensive Patients, Archives of Internal Medicine, vol.163, issue.5, pp.592-600, 2003.
DOI : 10.1001/archinte.163.5.592

B. Psaty, T. Koepsell, E. Wagner, J. Logerfo, and T. Inui, The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers, JAMA: The Journal of the American Medical Association, vol.263, issue.12
DOI : 10.1001/jama.263.12.1653

M. Amanzio, L. Corazzini, L. Vase, and F. Benedetti, A systematic review of adverse events in placebo groups of anti-migraine clinical trials, Pain, vol.146, issue.3, pp.261-270, 2009.
DOI : 10.1016/j.pain.2009.07.010

W. Rief, J. Avorn, and A. Barsky, Medication-Attributed Adverse Effects in Placebo Groups, Archives of Internal Medicine, vol.166, issue.2, 2006.
DOI : 10.1001/archinte.166.2.155

W. Rief, Y. Nestoriuc, S. Weiss, E. Welzel, A. Barsky et al., Meta-analysis of the placebo response in antidepressant trials, Journal of Affective Disorders, vol.118, issue.1-3, pp.1-31, 2009.
DOI : 10.1016/j.jad.2009.01.029

W. Rief, Y. Nestoriuc, V. Lilienfeld-toal, A. Dogan, I. Schreiber et al., Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials, Drug Safety, vol.38, issue.4, pp.1041-56, 2009.
DOI : 10.2165/11316580-000000000-00000

F. Feys, G. Bekkering, K. Singh, and D. Devroey, Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups? A protocol for a meta-epidemiological study of PDE-5 inhibitors. Syst Rev, p.54, 2012.

F. Antonaci, P. Chimento, H. Diener, G. Sances, and G. Bono, Lessons from placebo effects in migraine treatment, The Journal of Headache and Pain, vol.8, issue.1, pp.63-69, 2007.
DOI : 10.1007/s10194-007-0360-4

Q. Oui and . Qu, il arrive. 0 point Oui, en général. 1 point Rarement. 2 points Jamais, p.points

. Oui, 0 point Pas autant. 1 point Un peu seulement. 2 points Presque plus, p.points

. Autant-que-par-le-passé, 0 point Plus autant qu'avant. 1 point Vraiment moins qu'avant. 2 points Plus du tout. 3 points 35

J. De-fonctionner-au-ralenti, Jamais. 0 point Parfois. 1 point Très souvent. 2 points Presque toujours, p.points

. Autant, 0 point Un peu moins qu'avant. 1 point Bien moins qu'avant. 2 points Presque jamais, p.points